These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34399402)

  • 1. Computed tomography-defined low skeletal muscle mass as a prognostic marker for short-term mortality in critically ill patients: A systematic review and meta-analysis.
    Meyer HJ; Wienke A; Surov A
    Nutrition; 2021; 91-92():111417. PubMed ID: 34399402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
    Meyer HJ; Wienke A; Surov A
    Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019.
    Meyer HJ; Wienke A; Surov A
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):159-168. PubMed ID: 35018725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low skeletal muscle mass defined by thoracic CT as a prognostic marker in acute pulmonary embolism.
    Meyer HJ; Benkert F; Bailis N; Lerche M; Denecke T; Surov A
    Nutrition; 2022 Jun; 98():111622. PubMed ID: 35436690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
    Meyer HJ; Wienke A; Zamsheva M; Surov A
    Urol Int; 2023; 107(3):219-229. PubMed ID: 36455534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and mortality risk of low skeletal muscle mass in critically ill patients: an updated systematic review and meta-analysis.
    Yang H; Wan XX; Ma H; Li Z; Weng L; Xia Y; Zhang XM
    Front Nutr; 2023; 10():1117558. PubMed ID: 37252244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Meyer HJ; Strobel A; Wienke A; Surov A
    Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
    Meyer HJ; Wienke A; Surov A
    Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
    Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
    Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia as a predictor of mortality among the critically ill in an intensive care unit: a systematic review and meta-analysis.
    Zhang XM; Chen D; Xie XH; Zhang JE; Zeng Y; Cheng AS
    BMC Geriatr; 2021 Jun; 21(1):339. PubMed ID: 34078275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications.
    Fang Z; Du F; Shang L; Liu J; Ren F; Liu Y; Wu H; Liu Y; Li P; Li L
    Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):317-324. PubMed ID: 33063547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
    Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
    Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
    Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.
    Surov A; Meyer HJ; Hinnerichs M; Ferraro V; Zeremski V; Mougiakakos D; Saalfeld S; Wienke A; Strobel A; Wolleschak D
    Eur Radiol; 2024 Feb; 34(2):790-796. PubMed ID: 37178198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
    Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
    Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis.
    Xia W; Barazanchi AWH; MacFater WS; Hill AG
    Injury; 2019 Sep; 50(9):1565-1576. PubMed ID: 31280971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
    Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
    Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying critically ill patients with low muscle mass: Agreement between bioelectrical impedance analysis and computed tomography.
    Looijaard WGPM; Stapel SN; Dekker IM; Rusticus H; Remmelzwaal S; Girbes ARJ; Weijs PJM; Oudemans-van Straaten HM
    Clin Nutr; 2020 Jun; 39(6):1809-1817. PubMed ID: 31492456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
    March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
    Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.